Thu 04/28/2022 09:48 AM
Holland & Barret distressed update from Reorg's EMEA Core Credit team.
Holland & Barrett, or H&B, endured a difficult couple of months at the start of the year as the impact of the omicron variant of Covid-19 continued to disrupt trading. The U.K.-based health products retailer drew down £20 million under its £75 million RCF during January and a further £20 million during February to boost liquidity and fund working capital, sources told Reorg.
H&B’s net sales came in at £63.6...
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2024 Reorg Research, Inc. All rights reserved.